{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T17:25:52Z","timestamp":1795195552406,"version":"4.10.3"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70913-6","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T14:03:05Z","timestamp":1725026585000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gene profiling of Epstein-Barr Virus and human endogenous retrovirus in peripheral blood mononuclear cells of SLE patients: immune response implications"],"prefix":"10.1038","volume":"14","author":[{"given":"Yesit Bello","family":"Lemus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo Aroca","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisandro Pacheco","family":"Lugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena G\u00f3mez","family":"Escorcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00edna Zarate","family":"Pe\u00f1ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataly Solano","family":"Llanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Cadena","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio J.","family":"Acosta-Hoyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elkin Navarro","family":"Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"key":"70913_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/art.40396","volume":"70","author":"S Karrar","year":"2018","unstructured":"Karrar, S. & Cunninghame Graham, D. S. Abnormal B cell development in systemic lupus erythematosus. Arthritis Rheumatol. 70, 496\u2013507 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"70913_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.22265\/acnef.1.1.171","volume":"1","author":"LP Lugo","year":"2014","unstructured":"Lugo, L. P., Olmos, Y. D. & Mart\u00ednez, G. A. Biomarcadores en flu\u00eddos biol\u00f3gicos y su potencial uso como indicadores de nefritis l\u00fapica en individuos con lupus eritematoso sist\u00e9mico. Rev. Colomb. Nefrol. 1, 39\u201347 (2014).","journal-title":"Rev. Colomb. Nefrol."},{"key":"70913_CR3","first-page":"53","volume":"19","author":"A Garc\u00eda Tello","year":"2002","unstructured":"Garc\u00eda Tello, A., Villegas Mart\u00ednez, A. & Gonz\u00e1lez Fern\u00e1ndez, A. F. Manifestaciones hematol\u00f3gicas en el lupus eritematoso sist\u00e9mico. An.Med. Interna 19, 53\u201357 (2002).","journal-title":"An.Med. Interna"},{"key":"70913_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jdermsci.2014.12.004","volume":"77","author":"Z Wu","year":"2015","unstructured":"Wu, Z. et al. DNA methylation modulates HERV-E expression in CD4+ T cells from systemic lupus erythematosus patients. J. Dermatol. Sci. 77, 110\u2013116 (2015).","journal-title":"J. Dermatol. Sci."},{"key":"70913_CR5","first-page":"523","volume":"18","author":"A Piroozmand","year":"2017","unstructured":"Piroozmand, A., Kashani, H. H. & Zamani, B. Correlation between epstein-barr virus infection and disease activity of systemic lupus erythematosus: A cross-sectional study. Asian Pac. J. Cancer Prev. 18, 523\u2013527 (2017).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"70913_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson, D. A. Epstein-Barr virus: Exploiting the immune system. Nat. Rev. Immunol. 1, 75\u201382 (2001).","journal-title":"Nat. Rev. Immunol."},{"key":"70913_CR7","doi-asserted-by":"publisher","first-page":"e6473204","DOI":"10.1155\/2016\/6473204","volume":"2016","author":"AH Draborg","year":"2016","unstructured":"Draborg, A. H. et al. Impaired cytokine responses to Epstein-Barr virus antigens in systemic lupus erythematosus patients. J. Immunol. Res. 2016, e6473204 (2016).","journal-title":"J. Immunol. Res."},{"key":"70913_CR8","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1128\/JVI.74.3.1224-1233.2000","volume":"74","author":"AL Adamson","year":"2000","unstructured":"Adamson, A. L. et al. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 Activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J. Virol. 74, 1224\u20131233 (2000).","journal-title":"J. Virol."},{"key":"70913_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-017-0122-4","volume":"9","author":"G Guo","year":"2018","unstructured":"Guo, G. et al. The cytomegalovirus protein US31 induces inflammation through mono-macrophages in systemic lupus erythematosus by promoting NF-\u03baB2 activation. Cell Death Dis. 9, 1\u201315 (2018).","journal-title":"Cell Death Dis."},{"key":"70913_CR10","doi-asserted-by":"publisher","first-page":"830993","DOI":"10.3389\/fimmu.2022.830993","volume":"13","author":"V Laurynenka","year":"2022","unstructured":"Laurynenka, V., Ding, L., Kaufman, K. M., James, J. A. & Harley, J. B. A high prevalence of anti-EBNA1 heteroantibodies in systemic lupus erythematosus (SLE) supports anti-EBNA1 as an origin for SLE autoantibodies. Front. Immunol. 13, 830993 (2022).","journal-title":"Front. Immunol."},{"key":"70913_CR11","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1158\/1055-9965.EPI-05-0456","volume":"14","author":"CP Wild","year":"2005","unstructured":"Wild, C. P. Complementing the genome with an \u201cexposome\u201d: The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomark. Prev. 14, 1847\u20131850 (2005).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"70913_CR12","doi-asserted-by":"publisher","first-page":"e0203118","DOI":"10.1371\/journal.pone.0203118","volume":"13","author":"R Gonzalez-Quintial","year":"2018","unstructured":"Gonzalez-Quintial, R. et al. Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition. PLoS ONE 13, e0203118 (2018).","journal-title":"PLoS ONE"},{"key":"70913_CR13","first-page":"267","volume":"47","author":"Y Richaud-Patin","year":"1995","unstructured":"Richaud-Patin, Y., Alcocer-Varela, J. & Llorente, L. High levels of TH2 cytokine gene expression in systemic lupus erythematosus. Rev. Invest. Clin. 47, 267\u2013272 (1995).","journal-title":"Rev. Invest. Clin."},{"key":"70913_CR14","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1006\/cyto.1999.0512","volume":"11","author":"TF Liu","year":"1999","unstructured":"Liu, T. F., Jones, B. M., Wong, R. W. S. & Srivastava, G. Impaired production of Il-12 in systemic lupus erythematosus. III: Deficient il-12p40 gene expression and cross-regulation of Il-12, Il-10 and ifn-\u03b3 gene expression. Cytokine 11, 805\u2013811 (1999).","journal-title":"Cytokine"},{"key":"70913_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","volume":"24","author":"X Hu","year":"2006","unstructured":"Hu, X. et al. IFN-\u03b3 suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins. Immunity 24, 563\u2013574 (2006).","journal-title":"Immunity"},{"key":"70913_CR16","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1164\/rccm.201606-1278CI","volume":"194","author":"AB Mitchell","year":"2016","unstructured":"Mitchell, A. B., Oliver, B. G. G. & Glanville, A. R. translational aspects of the human respiratory virome. Am. J. Respir. Crit. Care Med. 194, 1458\u20131464 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"70913_CR17","doi-asserted-by":"publisher","first-page":"535738","DOI":"10.1155\/2013\/535738","volume":"2013","author":"AH Draborg","year":"2013","unstructured":"Draborg, A. H., Duus, K. & Houen, G. Epstein-Barr virus in systemic autoimmune diseases. Clin. Dev. Immunol. 2013, 535738 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"70913_CR18","doi-asserted-by":"publisher","first-page":"17331","DOI":"10.3390\/ijms160817331","volume":"16","author":"D Rigante","year":"2015","unstructured":"Rigante, D. & Esposito, S. Infections and systemic lupus erythematosus: Binding or sparring partners?. Int. J. Mol. Sci. 16, 17331\u201317343 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"70913_CR19","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri, M. et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis. Rheum 64, 2677\u20132686 (2012).","journal-title":"Arthritis. Rheum"},{"issue":"1","key":"70913_CR20","first-page":"1","volume":"32","author":"G Ruiz Irastorza","year":"2012","unstructured":"Ruiz Irastorza, G. et al. Diagnosis and treatment of lupus nephritis consensus document from the systemic auto-immune disease group (GEAS) of the Spanish society of internal medicine (SEMI) and spanish society of nephrology (S.E.N.). Nefrologia 32(1), 1\u201335 (2012).","journal-title":"Nefrologia"},{"key":"70913_CR21","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1101\/pdb.prot5439","volume":"2010","author":"DC Rio","year":"2010","unstructured":"Rio, D. C., Ares, M., Hannon, G. J. & Nilsen, T. W. Purification of RNA using TRIzol (TRI reagent). Cold Spring Harb. Protoc. 2010, 5439 (2010).","journal-title":"Cold Spring Harb. Protoc."},{"key":"70913_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"70913_CR23","doi-asserted-by":"publisher","first-page":"e1003925","DOI":"10.1371\/journal.pgen.1003925","volume":"9","author":"A Moreno-Estrada","year":"2013","unstructured":"Moreno-Estrada, A. et al. Reconstructing the population genetic history of the Caribbean. PLoS Genet. 9, e1003925 (2013).","journal-title":"PLoS Genet."},{"key":"70913_CR24","doi-asserted-by":"publisher","first-page":"102359","DOI":"10.1016\/j.jaut.2019.102359","volume":"110","author":"MD Catalina","year":"2020","unstructured":"Catalina, M. D., Owen, K. A., Labonte, A. C., Grammer, A. C. & Lipsky, P. E. The pathogenesis of systemic lupus erythematosus: Harnessing big data to understand the molecular basis of lupus. J. Autoimmun. 110, 102359 (2020).","journal-title":"J. Autoimmun."},{"key":"70913_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12519-019-00229-3","volume":"16","author":"L Pan","year":"2020","unstructured":"Pan, L., Lu, M.-P., Wang, J.-H., Xu, M. & Yang, S.-R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J. Pediatr. 16, 19\u201330 (2020).","journal-title":"World J. Pediatr."},{"key":"70913_CR26","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/BOR.0000000000000318","volume":"28","author":"M Barbhaiya","year":"2016","unstructured":"Barbhaiya, M. & Costenbader, K. H. Environmental exposures and the development of systemic lupus erythematosus. Curr. Opin. Rheumatol. 28, 497\u2013505 (2016).","journal-title":"Curr. Opin. Rheumatol."},{"key":"70913_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s12026-018-8993-8","volume":"66","author":"J Ram\u00edrez-Bello","year":"2018","unstructured":"Ram\u00edrez-Bello, J. et al. Tumor necrosis factor gene polymorphisms are associated with systemic lupus erythematosus susceptibility or lupus nephritis in Mexican patients. Immunol. Res. 66, 348\u2013354 (2018).","journal-title":"Immunol. Res."},{"key":"70913_CR28","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/rheumatology\/35.11.1067","volume":"35","author":"A Studnicka-Benke","year":"1996","unstructured":"Studnicka-Benke, A., Steiner, G., Petera, P. & Smolen, J. S. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br. J. Rheumatol. 35, 1067\u20131074 (1996).","journal-title":"Br. J. Rheumatol."},{"key":"70913_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/03009740802409496","volume":"38","author":"HM Habib","year":"2009","unstructured":"Habib, H. M., Taher, T. E., Isenberg, D. A. & Mageed, R. A. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha. Scand. J. Rheumatol. 38, 112\u2013120 (2009).","journal-title":"Scand. J. Rheumatol."},{"key":"70913_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/j.1365-2249.1991.tb05736.x","volume":"85","author":"K Mitamura","year":"1991","unstructured":"Mitamura, K. et al. Impaired tumour necrosis factor-alpha (TNF-alpha) production and abnormal B cell response to TNF-alpha in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 85, 386\u2013391 (1991).","journal-title":"Clin. Exp. Immunol."},{"key":"70913_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s100670050045","volume":"18","author":"EM Davas","year":"1999","unstructured":"Davas, E. M. et al. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin. Rheumatol. 18, 17\u201322 (1999).","journal-title":"Clin. Rheumatol."},{"key":"70913_CR32","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.cyto.2011.08.026","volume":"56","author":"M Postal","year":"2011","unstructured":"Postal, M. & Appenzeller, S. The role of tumor necrosis factor-alpha (TNF-\u03b1) in the pathogenesis of systemic lupus erythematosus. Cytokine 56, 537\u2013543 (2011).","journal-title":"Cytokine"},{"key":"70913_CR33","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/ar770","volume":"5","author":"M Aringer","year":"2003","unstructured":"Aringer, M. & Smolen, J. S. SLE - Complex cytokine effects in a complex autoimmune disease: Tumor necrosis factor in systemic lupus erythematosus. Arthritis. Res. Ther 5, 172\u2013177 (2003).","journal-title":"Arthritis. Res. Ther"},{"key":"70913_CR34","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1002\/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K","volume":"30","author":"D Kontoyiannis","year":"2000","unstructured":"Kontoyiannis, D. & Kollias, G. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol. 30, 2038\u20132047 (2000).","journal-title":"Eur. J. Immunol."},{"key":"70913_CR35","doi-asserted-by":"publisher","first-page":"e00258","DOI":"10.1128\/JVI.00258-20","volume":"94","author":"X Liu","year":"2020","unstructured":"Liu, X., Sadaoka, T., Krogmann, T. & Cohen, J. I. Epstein-Barr virus (EBV) tegument protein BGLF2 suppresses type I interferon signaling to promote EBV reactivation. J. Virol. 94, e00258-e320 (2020).","journal-title":"J. Virol."},{"key":"70913_CR36","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1128\/JVI.01921-15","volume":"90","author":"Y Li","year":"2016","unstructured":"Li, Y. et al. Epstein-Barr virus BZLF1-mediated downregulation of proinflammatory factors is essential for optimal lytic viral replication. J. Virol. 90, 887\u2013903 (2016).","journal-title":"J. Virol."},{"key":"70913_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S1074-7613(01)00226-6","volume":"15","author":"TE Morrison","year":"2001","unstructured":"Morrison, T. E., Mauser, A., Wong, A., Ting, J. P. & Kenney, S. C. Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein. Immunity 15, 787\u2013799 (2001).","journal-title":"Immunity"},{"key":"70913_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1523-1747.1999.00728.x","volume":"113","author":"C Hohenadl","year":"1999","unstructured":"Hohenadl, C. et al. Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J. Investig. Dermatol. 113, 587\u2013594 (1999).","journal-title":"J. Investig. Dermatol."},{"key":"70913_CR39","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1128\/JVI.79.7.4415-4424.2005","volume":"79","author":"N Ahsan","year":"2005","unstructured":"Ahsan, N., Kanda, T., Nagashima, K. & Takada, K. Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J. Virol. 79, 4415\u20134424 (2005).","journal-title":"J. Virol."},{"key":"70913_CR40","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.27421","volume":"62","author":"JB Harley","year":"2010","unstructured":"Harley, J. B. & James, J. A. Everyone comes from somewhere: Systemic lupus erythematosus (SLE) and Epstein-Barr Virus, induction of host interferon (INF) and humoral anti-EBNA1 immunity. Arthritis. Rheum. 62, 1571\u20131575 (2010).","journal-title":"Arthritis. Rheum."},{"key":"70913_CR41","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","volume":"172","author":"I Kang","year":"2004","unstructured":"Kang, I. et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J. Immunol. 172, 1287\u20131294 (2004).","journal-title":"J. Immunol."},{"key":"70913_CR42","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","volume":"174","author":"AJ Gross","year":"2005","unstructured":"Gross, A. J., Hochberg, D., Rand, W. M. & Thorley-Lawson, D. A. EBV and systemic lupus erythematosus: A new perspective. J. Immunol. 174, 6599\u20136607 (2005).","journal-title":"J. Immunol."},{"key":"70913_CR43","doi-asserted-by":"publisher","first-page":"R295","DOI":"10.1186\/ar1181","volume":"6","author":"UY Moon","year":"2004","unstructured":"Moon, U. Y. et al. Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res. Ther. 6, R295-302 (2004).","journal-title":"Arthritis Res. Ther."},{"key":"70913_CR44","doi-asserted-by":"publisher","first-page":"12251","DOI":"10.1128\/JVI.01407-12","volume":"86","author":"GL Bentz","year":"2012","unstructured":"Bentz, G. L., Shackelford, J. & Pagano, J. S. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation. J. Virol. 86, 12251\u201312261 (2012).","journal-title":"J. Virol."},{"key":"70913_CR45","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1128\/JVI.01052-09","volume":"84","author":"P Johansson","year":"2010","unstructured":"Johansson, P., Jansson, A., R\u00fcetschi, U. & Rymo, L. The p38 signaling pathway upregulates expression of the Epstein-Barr Virus LMP1 oncogene. J. Virol. 84, 2787\u20132797 (2010).","journal-title":"J. Virol."},{"key":"70913_CR46","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.18632\/oncotarget.3331","volume":"6","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs\/HIF-1 pathway in nasopharyngeal carcinoma. Oncotarget 6, 5804\u20135817 (2015).","journal-title":"Oncotarget"},{"key":"70913_CR47","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1093\/emboj\/cdg284","volume":"22","author":"N Lam","year":"2003","unstructured":"Lam, N. & Sugden, B. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. EMBO. J. 22, 3027\u20133038 (2003).","journal-title":"EMBO. J."},{"key":"70913_CR48","first-page":"1678","volume":"29","author":"M Okada","year":"2002","unstructured":"Okada, M. et al. Role of DNA methylation in transcription of human endogenous retrovirus in the pathogenesis of systemic lupus erythematosus. J. Rheumatol. 29, 1678\u20131682 (2002).","journal-title":"J. Rheumatol."},{"key":"70913_CR49","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/apm.13039","volume":"128","author":"R Talotta","year":"2020","unstructured":"Talotta, R., Atzeni, F. & Laska, M. J. The contribution of HERV-E clone 4\u20131 and other HERV-E members to the pathogenesis of rheumatic autoimmune diseases. APMIS 128, 367\u2013377 (2020).","journal-title":"APMIS"},{"key":"70913_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1874312901307010013","volume":"7","author":"N Tugnet","year":"2013","unstructured":"Tugnet, N., Rylance, P., Roden, D., Trela, M. & Nelson, P. Human endogenous retroviruses (HERVs) and autoimmune rheumatic disease: Is there a link?. Open Rheumatol. J. 7, 13\u201321 (2013).","journal-title":"Open Rheumatol. J."},{"key":"70913_CR51","doi-asserted-by":"publisher","first-page":"3208","DOI":"10.4049\/jimmunol.149.10.3208","volume":"149","author":"K Sugita","year":"1992","unstructured":"Sugita, K. et al. CD27, a member of the nerve growth factor receptor family, is preferentially expressed on CD45RA+ CD4 T cell clones and involved in distinct immunoregulatory functions. J. Immunol. 149, 3208\u20133216 (1992).","journal-title":"J. Immunol."},{"key":"70913_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1191\/0961203304lu1014oa","volume":"13","author":"T D\u00f6rner","year":"2004","unstructured":"D\u00f6rner, T. & Lipsky, P. E. Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosus. Lupus 13, 283\u2013289 (2004).","journal-title":"Lupus"},{"key":"70913_CR53","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/labinvest.3700468","volume":"86","author":"KRM Blenman","year":"2006","unstructured":"Blenman, K. R. M. et al. IL-10 regulation of lupus in the NZM2410 murine model. Lab. Investig. 86, 1136\u20131148 (2006).","journal-title":"Lab. Investig."},{"key":"70913_CR54","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/rheumatology\/ker198","volume":"50","author":"G-S Ling","year":"2011","unstructured":"Ling, G.-S., Cook, H. T., Botto, M., Lau, Y.-L. & Huang, F.-P. An essential protective role of IL-10 in the immunological mechanism underlying resistance vs susceptibility to lupus induction by dendritic cells and dying cells. Rheumatol. (Oxford) 50, 1773\u20131784 (2011).","journal-title":"Rheumatol. (Oxford)"},{"key":"70913_CR55","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q","volume":"28","author":"CJP Clarke","year":"1998","unstructured":"Clarke, C. J. P., Hales, A., Hunt, A. & Foxwell, B. M. J. IL-10-mediated suppression of TNF-\u03b1 production is independent of its ability to inhibit NF\u03baB activity. Eur. J. Immunol. 28, 1719\u20131726 (1998).","journal-title":"Eur. J. Immunol."},{"key":"70913_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pr3010001","volume":"3","author":"S Maiti","year":"2015","unstructured":"Maiti, S., Dai, W., Alaniz, R. C., Hahn, J. & Jayaraman, A. Mathematical modeling of pro- and anti-inflammatory signaling in macrophages. Processes 3, 1\u201318 (2015).","journal-title":"Processes"},{"key":"70913_CR57","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1084\/jem.174.4.915","volume":"174","author":"R de Waal Malefyt","year":"1991","unstructured":"de Waal Malefyt, R. et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915\u2013924 (1991).","journal-title":"J. Exp. Med."},{"key":"70913_CR58","doi-asserted-by":"publisher","first-page":"17696","DOI":"10.1074\/jbc.M700209200","volume":"282","author":"CT Ranjith-Kumar","year":"2007","unstructured":"Ranjith-Kumar, C. T. et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J. Biol. Chem. 282, 17696\u201317705 (2007).","journal-title":"J. Biol. Chem."},{"key":"70913_CR59","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1084\/jem.20081761","volume":"206","author":"D Iwakiri","year":"2009","unstructured":"Iwakiri, D. et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from Toll-like receptor 3. J. Exp. Med. 206, 2091\u20132099 (2009).","journal-title":"J. Exp. Med."},{"key":"70913_CR60","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1089\/vim.2021.0006","volume":"34","author":"M Razin","year":"2021","unstructured":"Razin, M. et al. TLR3\\TLR7 as differentially expressed markers among viral, nonviral, and autoimmune diseases in Egyptian patients. Viral Immunol. 34, 607\u2013621 (2021).","journal-title":"Viral Immunol."},{"key":"70913_CR61","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1006\/scbi.2001.0410","volume":"11","author":"AG Eliopoulos","year":"2001","unstructured":"Eliopoulos, A. G. & Young, L. S. LMP1 structure and signal transduction. Semin. Cancer Biol. 11, 435\u2013444 (2001).","journal-title":"Semin. Cancer Biol."},{"key":"70913_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41591-018-0254-9","volume":"25","author":"S Caielli","year":"2019","unstructured":"Caielli, S. et al. A CD4+ T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate. Nat. Med. 25, 75\u201381 (2019).","journal-title":"Nat. Med."},{"key":"70913_CR63","doi-asserted-by":"publisher","first-page":"101330","DOI":"10.1016\/j.smim.2019.101330","volume":"44","author":"J Geginat","year":"2019","unstructured":"Geginat, J. et al. IL-10 producing regulatory and helper T-cells in systemic lupus erythematosus. Semin. Immunol. 44, 101330 (2019).","journal-title":"Semin. Immunol."},{"key":"70913_CR64","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei, C. et al. A new population of cells lacking expression of CD27 represents a notable component of the b cell memory compartment in systemic lupus erythematosus1. J. Immunol. 178, 6624\u20136633 (2007).","journal-title":"J. Immunol."},{"key":"70913_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2011.00081","author":"Y-CB Wu","year":"2011","unstructured":"Wu, Y.-C.B., Kipling, D. & Dunn-Walters, D. K. The relationship between CD27 negative and positive B cell populations in human peripheral blood. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2011.00081 (2011).","journal-title":"Front. Immunol."},{"key":"70913_CR66","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cei.13615","volume":"205","author":"Y Li","year":"2021","unstructured":"Li, Y., Li, Z. & Hu, F. Double-negative (DN) B cells: an under-recognized effector memory B cell subset in autoimmunity. Clin. Exp. Immunol. 205, 119\u2013127 (2021).","journal-title":"Clin. Exp. Immunol."},{"key":"70913_CR67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/ard.2008.096495","volume":"69","author":"AM Jacobi","year":"2010","unstructured":"Jacobi, A. M. et al. HLA-DRhigh\/CD27high plasmablasts indicate active disease in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 69, 305\u2013308 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"70913_CR68","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1099\/vir.0.81890-0","volume":"88","author":"G Mameli","year":"2007","unstructured":"Mameli, G. et al. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus\/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J. Gen. Virol. 88, 264\u2013274 (2007).","journal-title":"J. Gen. Virol."},{"key":"70913_CR69","doi-asserted-by":"publisher","first-page":"e28350","DOI":"10.1002\/jmv.28350","volume":"95","author":"K Kitsou","year":"2023","unstructured":"Kitsou, K., Lagiou, P. & Magiorkinis, G. Human endogenous retroviruses in cancer: Oncogenesis mechanisms and clinical implications. J. Med. Virol. 95, e28350 (2023).","journal-title":"J. Med. Virol."},{"key":"70913_CR70","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2016.01.011","volume":"164","author":"B Sun","year":"2016","unstructured":"Sun, B. et al. DNA methylation perspectives in the pathogenesis of autoimmune diseases. Clin. Immunol. 164, 21\u201327 (2016).","journal-title":"Clin. Immunol."},{"key":"70913_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40744-015-0014-y","volume":"2","author":"M Relle","year":"2015","unstructured":"Relle, M., Foehr, B. & Schwarting, A. Epigenetic aspects of systemic lupus erythematosus. Rheumatol. Ther. 2, 33\u201346 (2015).","journal-title":"Rheumatol. Ther."}],"updated-by":[{"DOI":"10.1038\/s41598-024-73833-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70913-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T07:05:25Z","timestamp":1727334325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70913-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70913"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70913-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4361087\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-73833-7","URL":"https:\/\/doi.org\/10.1038\/s41598-024-73833-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20236"}}